Q4 2022 Holdings
Filed 2023-02-13 | 61 holdings | $476.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics IncCall | CALL | 23282W905 | $18.3M | 400,000 | 3.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $18.3M | 400,000 | 3.8% |
| Moderna Inc(MRNA) | COM | 60770K107 | $18.0M | 100,000 | 3.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $17.6M | 170,000 | 3.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $16.6M | 150,000 | 3.5% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $15.6M | 100,000 | 3.3% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $15.1M | 60,000 | 3.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $15.1M | 750,000 | 3.2% |
| Cigna Corp New(CI) | COM | 125523100 | $14.9M | 45,000 | 3.1% |
| Madrigal Pharmaceuticals IncPut | PUT | 558868955 | $14.5M | 50,000 | 3.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $14.1M | 100,000 | 3.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $13.7M | 360,000 | 2.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $13.6M | 275,000 | 2.9% |
| Guardant Health Inc(GH) | COM | 40131M109 | $12.9M | 475,000 | 2.7% |
| Elevance Health Inc(ELV) | COM | 036752103 | $12.8M | 25,000 | 2.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $12.5M | 550,000 | 2.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $11.7M | 44,000 | 2.5% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $10.3M | 43,000 | 2.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $10.3M | 120,000 | 2.2% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $9.7M | 200,000 | 2.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $9.5M | 140,000 | 2.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $9.3M | 625,000 | 2.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $9.1M | 115,000 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.3M | 35,000 | 1.7% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $8.3M | 65,000 | 1.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $8.2M | 100,000 | 1.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $8.1M | 50,000 | 1.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $6.9M | 210,000 | 1.4% |
| Penumbra Inc(PEN) | COM | 70975L107 | $6.7M | 30,000 | 1.4% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $6.5M | 84,000 | 1.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $6.0M | 220,000 | 1.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.8M | 370,000 | 1.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.6M | 600,000 | 1.2% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $5.3M | 270,000 | 1.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $5.2M | 150,000 | 1.1% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $5.0M | 20,000 | 1.0% |
| Cooper COS Inc | COM NEW | 216648402 | $5.0M | 15,000 | 1.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $4.7M | 125,000 | 1.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $4.6M | 175,000 | 1.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $4.4M | 240,000 | 0.9% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $4.4M | 131,000 | 0.9% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $4.3M | 109,000 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $4.0M | 327,000 | 0.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $3.8M | 70,000 | 0.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $3.8M | 100,000 | 0.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.8M | 10,000 | 0.8% |
| Natera Inc(NTRA) | COM | 632307104 | $3.5M | 87,000 | 0.7% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $3.4M | 100,000 | 0.7% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $3.2M | 85,000 | 0.7% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $3.0M | 130,000 | 0.6% |